目的 探讨肿瘤患儿静脉化疗安全管理的方法。方法 统计分析2013-01至2015-01医院儿科静脉化疗技术管理小组儿科肿瘤患儿118例,化疗药物中心静脉导管输注率、化疗药物外渗率、患者满意率及投诉发生的情况,并与2012年来实行静脉化疗的安全管理的数据进行比较。结果 化疗药物中心静脉导管输注率为98.5%,化疗药物外渗率为0%,患者满意率98.2%,无投诉。2012年儿科病区收治肿瘤患儿62例,化疗药物中心静脉输注率86.2%,化疗药物外渗率为3.5%,患者满意率95.9%,有3例投诉。与2012年数据相比,各项指标均有改善,其中化疗药物中心静脉导管输注率(χ2=178.3,P<0.0001),药物外渗率(χ2=72.5,P<0.0001),患儿及家长的满意率(χ2=12.2,P<0.0001),均有统计学意义。结论 儿科肿瘤患儿静脉化疗的安全管理方法效果肯定,值得推荐。
Abstract
Objective To study the safety management method of intravenous chemotherapy in children with tumor. Methods Data of this pediatric department were collected, e.g. rate of central venous chemotherapeutics infusion, chemotherapy drugs exosmosis, patient satisfaction rate and complaints, etc. And those data were compared with those of 2012 before the implementation of intravenous chemotherapy safety management. Results There were 118 children with tumor in the department from January 2013 to January 2015, and the rate of central venous chemotherapeutics infusion was 98.5%, chemotherapy drugs exosmosis was 0, and patient satisfaction rate was 98.2% with no complaints. However, there were 62 children with tumor in 2012, and the rate of central venous chemotherapeutics infusion was 86.2%, chemotherapy drugs exosmosis was 3.5%, and patients satisfaction rate was 95.9% with 3 children making complaints. Compared with data of 2012, each index improved, including the rate of central venous chemotherapeutics infusion (χ2=178.3, P<0.0001), chemotherapy drugs exosmosis (χ2=72.5, P<0.0001), satisfaction of patients and family (χ2=12.2, P<0.0001). Conclusions The safety management method of intravenous chemotherapy in children with tumor has positive effects, and worth recommendation.
关键词
儿科 /
静脉化疗 /
规范管理
Key words
pediatric /
intravenous therapy /
standard management
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 王淑贤,马 静.加强肿瘤科化疗安全管理研究[J].齐鲁护理杂志,2008,14(5):94-95.
[2] 刘 慧,钱红英,胡蓓蓓.肺癌患者静脉化疗安全用药的护理管理[J].护士进修杂志,2009,24(10):889-890.
[3] 张 莹,高淑荣,于 伟.化疗药物静脉输注安全管理[J].吉林医学,2011,32(8):1578-1579.
[4] 嵇绍兵,徐珍荣.化疗药物输注安全管理探讨[J],临床合理用药杂志,2012,5(2A): 153-154.
[5] Goolsby T V,Lombardo F A. Extravasation of chemotherapeutic agents: prevention and treatment[J]. Semin Oncol, 2006,33(1):139-143.
[6] Schrijvers D L. Extravasation: a dreaded complication of chemotherapy[J]. Ann Oncol,2003,14(s3): s26-30.
[7] Alfaro-Rubio A, Sanmartin O, Requena C, et al. Extravasation of cytostatic agents:a serious complication of oncological treatment[J]. Actas Dermosifiliogr, 2006,97(3):169-176.
[8] Chanes D C,Goncalves D L,Pedreira M, et al. Antineoplastic agents extravasation from peripheral intravenous line in children:a simple strategy for a safer nursing care[J]. Eur J Oncol Nurs,2012,16(1):17-25.
[9] Thakur J S, Chauhan C G, Diwana V K, et al. Extravasational side effects of cytotoxic drugs: a preventable catastrophe[J].Indian J Plast Surg,2008,41(2):145-150.
[10] 胡 雁. 用循证护理的观念评估“临床实践指南”[J].护士进修杂志,2005,20(4):309-311.
[11] 言克莉,顾则娟,李金华, 等.应用护理质量指标提高静脉化疗护理质量的实践[J],中华护理杂志,2013,48(3):232-234.